Welcome to ENDO 2022 Medfyle Meeting Coverage.
In this program, we offer you a range of conferences summaries, interviews, and poster podcasts from presentations held at ENDO 2022.
ENDO is the foremost meeting in endocrinology, welcoming leading experts, researchers, and the most respected clinicians to share the latest developments in endocrine research.
If you have any comments or need any help, please complete our feedback survey or contact us.
Take the pre test
Deep Dive on incretin therapy
Introduction: Incretin Hormones and Glucagon
Dual Incretin Receptor Agonists and Glycemic Control
Cardiovascular Benefits of Dual Incretin Agonists
Dual Incretin Receptor Agonists and body weight
Glucagon action: New twists for an old peptide
What potential advantages might triple incretin agonists have over dual agonists?
What new aspects have been understood with regards to the action of glucagon and how is this peptide being exploited from a therapeutic standpoint?
What role does GIP have in obesity?
Where might dual incretin agonists be placed in the therapeutic algorithm for type 2 diabetes?
Deep Dive on Advances in Insulin and Its Delivery
Insulin-Only Bionic Pancreas Pivotal Trial
Insulin-Only Bioninc Pancreas Pivotal Trial Lispro/Aspart vs Fast Acting Insulin Aspart
Insulin Access in the USA
Is the Pen Mightier than the Pump? Integration of Smart Pens in Clinical Practice.
What are some of the advantages of insulin pumps over pens, and vice versa?
What do patients consider most when deciding to adopt an insulin pen or pump?
Do insulin pumps allow for better control of glycemia?
Which patients would be most appropriate for insulin pumps or pens?
THIS ACTIVITY IS SUPPORTED BY AN EDUCATIONAL GRANT FROM LILLY